Every person with hemophilia is unique, especially with a complication like an inhibitor, columnist Cazandra Campos-MacDonald writes.

The first hemophilia B patient at the Loma Linda University Health Hemophilia Treatment Center to receive Hympavzi is a ...

Hemophilia may impose some limitations, but it doesn't stop columnist G Shellye Horowitz from finding ways to fly through the ...

Altuvoct (efanesoctocog alfa) was approved in the U.K. as a treatment for patients with moderate or severe hemophilia A ages ...

Ixinity (trenonacog alfa) can effectively prevent and controlled bleeds in young children with severe or moderately severe ...

Columnist G Shellye Horowitz shares her approach to dating with chronic illness, particularly regarding when to discuss ...

Four years after receiving Hemgenix in a Phase 3 trial, bleeding rates and the use of replacement therapy are low for men ...

Columnist Alliah Czarielle discusses the benefits — and potential risks — of several tools that can be useful in a hemophilia household.

Columnist Jennifer Lynne stresses the significance of hidden symptoms in the lives of those with bleeding disorders.

Last night, I had very little left in the tank. The past few weeks have brought unique challenges and responsibilities that left me weary. As I started thinking about my column for this week, I ...